［1］Gibson RA, Neumann MA, Makrides M. Effect of increasing breast milk docosahexaenoic acid on plasma and erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants［J］. Eur J Clin Nutr, 1997, 51(9): 578-584.

［2］Sokolov AV, Pulina MO, Zakharova ET, Susorova AS, Runova OL, Kolodkin NI, et al. Identification and isolation from breast milk of ceruloplasmin-lactoferrin complex［J］. Biochemistry (Mosc), 2006, 71(2): 160-166.

［3］Rodriguez A, Raederstorff D, Sarda P, Lauret C, Mendy F, Descomps B. Preterm infant formula supplementation with alpha linolenic acid and docosahexaenoic acid［J］. Eur J Clin Nutr, 2003, 57(6): 727-734.

［4］Yen MH, Chiu CH, Huang YC, Lin TY. Effects of lactoferrin-containing formula in the prevention of enterovirus and rotavirus infection and impact on serum cytokine levels: a randomized trial［J］. Chang Gung Med J, 2011, 34(4): 395-402.

［5］Marchbank T, Weaver G, NilsenHamilton M, Playford RJ. Pancreatic secretory trypsin inhibitor is a major motogenic and protective factor in human breast milk［J］. Am J Physiol Gastrointest Liver Physiol, 2009, 296(4):G697-G703.

［6］Mossberg AK, Puchades M, Halskau O, Baumann A, Lanekoff I, Chao Y, et al. HAMLET interacts with lipid membranes and perturbs their structure and integrity［J］. PLoS One, 2010, 5(2): e9384.

［7］Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14［J］. Cell, 1993, 75(5): 843-854.

［8］Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans［J］. Nature, 2000, 403(6772): 901-906.

［9］Ruvkun G. Molecular biology. Glimpses of a tiny RNA world［J］. Science, 2001, 294(5543): 797-799.

［10］Lim LP, Glasner ME, Yekta S, Burge CB, Bartel DP. Vertebrate microRNA genes［J］. Science, 2003, 299(5612): 1540.

［11］Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay［J］. Nat Rev Genet, 2010, 11(9): 597-610.

［12］Sandhu S, Garzon R. Potential applications of microRNAs in cancer diagnosis, prognosis, and treatment［J］. Semin Oncol, 2011, 38(6): 781-787.

［13］Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, et al. The microRNA spectrum in 12 body fluids［J］. Clin Chem, 2010, 56(11): 1733-1741.

［14］Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases［J］. Cell Res, 2008, 18(10): 997-1006.

［15］Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection［J］. Proc Natl Acad Sci U S A, 2008, 105(30):10513-10518.

［16］Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E, et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection［J］. Clin Cancer Res, 2009, 15(17): 5473-5477.

［17］Hanke M, Hoefig K, Merz H, Feller AC, Kausch I, Jocham D, et al. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer［J］. Urol Oncol, 2010, 28(6): 655-661.

［18］Montenegro D, Romero R, Pineles BL, Tarca AL, Kim YM, Draghici S, et al. Differential expression of microRNAs with progression of gestation and inflammation in the human chorioamniotic membranes［J］. Am J Obstet Gynecol, 2007, 197(3): 289.e1-6.

［19］Iguchi H, Kosaka N, Ochiya T. Secretory microRNAs as a versatile communication tool［J］. Commun Integr Biol, 2010, 3(5): 478-481.